title: Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein E.
abstract: Hepatitis C virus (HCV) is a major cause of liver disease worldwide and HCV infection represents a major health problem. HCV associates with host lipoproteins forming host/viral hybrid complexes termed lipoviral particles. Apolipoprotein E (apoE) is a lipoprotein component that interacts with heparan sulfate proteoglycans (HSPG) to mediate hepatic lipoprotein uptake, and may likewise mediate HCV entry. We sought to define the functional regions of apoE with an aim to identify critical apoE binding partners involved in HCV infection. Using adenoviral vectors and siRNA to modulate apoE expression we show a direct correlation of apoE expression and HCV infectivity, whereas no correlation exists with viral protein expression. Mutating the HSPG binding domain (HSPG-BD) of apoE revealed key residues that are critical for mediating HCV infection. Furthermore, a novel synthetic peptide that mimics apoE's HSPG-BD directly and competitively inhibits HCV infection. Genetic knockdown of the HSPG proteins syndecan (SDC) 1 and 4 revealed that SDC4 principally mediates HCV entry. Our data demonstrate that HCV uses apoE-SDC4 interactions to enter hepatoma cells and establish infection. Targeting apoE-SDC interactions could be an alternative strategy for blocking HCV entry, a critical step in maintaining chronic HCV infection.
authors.affiliation: Inserm, U1110, Research Institute on Viral and Hepatic Disease, Strasbourg, France; Université de Strasbourg, Strasbourg, France.
authors.forename: Mathieu
authors.initials: M
authors.lastname: Lefèvre
authors.affiliation: Inserm, U1110, Research Institute on Viral and Hepatic Disease, Strasbourg, France; Université de Strasbourg, Strasbourg, France.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Felmlee
authors.affiliation: Inserm, U1110, Research Institute on Viral and Hepatic Disease, Strasbourg, France; Université de Strasbourg, Strasbourg, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Parnot
authors.affiliation: Inserm, U1110, Research Institute on Viral and Hepatic Disease, Strasbourg, France; Université de Strasbourg, Strasbourg, France; Pôle hépato-digestif, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Baumert
authors.affiliation: Inserm, U1110, Research Institute on Viral and Hepatic Disease, Strasbourg, France; Université de Strasbourg, Strasbourg, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Schuster
mesh_terms: D000595:Amino Acid Sequence; D001057:Apolipoproteins E / Q000737:chemistry / Q000378:metabolism*; D002460:Cell Line; D016174:Hepacivirus / Q000502:physiology*; D019812:Heparan Sulfate Proteoglycans / Q000378:metabolism; D006526:Hepatitis C / Q000378:metabolism / Q000473:pathology / Q000821:virology; D006801:Humans; D008055:Lipids / Q000737:chemistry*; D008969:Molecular Sequence Data; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D053671:Syndecan-4 / Q000378:metabolism*; D053586:Virus Internalization
chemical_list: D001057:Apolipoproteins E; D019812:Heparan Sulfate Proteoglycans; D008055:Lipids; D053671:Syndecan-4
references.citation: J Clin Invest. 2007 Jan;117(1):153-64
references.pmid: 17200715
references.citation: J Virol. 2007 Dec;81(24):13783-93
references.pmid: 17913825
references.citation: J Exp Med. 2010 Aug 30;207(9):2019-31
references.pmid: 20713596
references.citation: Hepatology. 2012 Aug;56(2):484-91
references.pmid: 22334503
references.citation: J Virol. 2003 May;77(9):5401-14
references.pmid: 12692242
references.citation: Hepatology. 2012 Jan;55(1):277-86
references.pmid: 21898481
references.citation: Hepatology. 2010 Jan;51(1):43-53
references.pmid: 20014138
references.citation: J Infect Dis. 2012 Jun;205(11):1654-64
references.pmid: 22457281
references.citation: Dev Cell. 2013 Mar 11;24(5):472-85
references.pmid: 23453597
references.citation: J Infect Dis. 2006 Feb 1;193(3):442-50
references.pmid: 16388493
references.citation: Nucleic Acids Res. 2008 May;36(9):3054-64
references.pmid: 18400784
references.citation: J Clin Invest. 2009 Nov;119(11):3236-45
references.pmid: 19805913
references.citation: Hepatology. 2007 Dec;46(6):1722-31
references.pmid: 18000990
references.citation: Gastroenterology. 2012 May;142(6):1340-1350.e1
references.pmid: 22537441
references.citation: Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9505-10
references.pmid: 23690609
references.citation: J Biol Chem. 2001 Oct 19;276(42):39138-44
references.pmid: 11500500
references.citation: J Clin Invest. 1991 Jul;88(1):270-81
references.pmid: 2056122
references.citation: Virology. 2009 Nov 10;394(1):99-108
references.pmid: 19751943
references.citation: Gastroenterology. 2012 Sep;143(3):e1-e7
references.pmid: 22796239
references.citation: Gastroenterology. 2011 Sep;141(3):1057-66
references.pmid: 21699799
references.citation: J Gen Virol. 2005 Dec;86(Pt 12):3189-3199
references.pmid: 16298963
references.citation: Hepatology. 2010 Apr;51(4):1144-57
references.pmid: 20069648
references.citation: Gastroenterology. 2012 Jul;143(1):223-233.e9
references.pmid: 22503792
references.citation: Proc Natl Acad Sci U S A. 2006 May 9;103(19):7408-13
references.pmid: 16651538
references.citation: Curr Eye Res. 2009 Feb;34(2):99-102
references.pmid: 19219680
references.citation: Hepatology. 2012 Apr;55(4):998-1007
references.pmid: 22121002
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5848-53
references.pmid: 17376867
references.citation: Viruses. 2013 May 23;5(5):1292-324
references.pmid: 23698400
references.citation: J Med Virol. 2007 Jun;79(6):714-23
references.pmid: 17457918
references.citation: Front Biosci (Landmark Ed). 2009 Jan 01;14:3274-85
references.pmid: 19273272
references.citation: J Biol Chem. 2011 Jan 28;286(4):3018-32
references.pmid: 21056986
references.citation: J Virol. 2008 Oct;82(19):9647-56
references.pmid: 18667498
references.citation: Eur J Immunol. 2004 Oct;34(10):2834-42
references.pmid: 15368299
references.citation: J Virol. 2012 Jul;86(13):7256-67
references.pmid: 22532692
references.citation: J Virol. 2006 Nov;80(21):10579-90
references.pmid: 16928753
references.citation: J Virol. 2013 Jun;87(12):6866-75
references.pmid: 23576506
references.citation: J Biol Chem. 2003 Oct 17;278(42):41003-12
references.pmid: 12867431
references.citation: J Clin Invest. 2013 Jun;123(6):2742-51
references.pmid: 23676495
references.citation: J Virol. 2002 Apr;76(8):4008-21
references.pmid: 11907240
references.citation: Cell Host Microbe. 2013 Mar 13;13(3):302-13
references.pmid: 23498955
references.citation: FEBS J. 2010 Oct;277(19):3876-89
references.pmid: 20840585
references.citation: J Virol. 2006 Jun;80(11):5308-20
references.pmid: 16699011
references.citation: J Virol. 1996 Jul;70(7):4805-10
references.pmid: 8676512